Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques.
about
Perspectives for therapeutic HPV vaccine developmentMolecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccinationDNA vaccines for cervical cancerElectroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developmentsIntramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions.Therapeutic HPV DNA vaccines.Immunotherapy for cervical cancer: Research status and clinical potentialIdentification of novel epitopes from human papillomavirus type 18 E7 that can sensitize PBMCs of multiple HLA class I against human cervical cancer.Immune therapy for human papillomaviruses-related cancers.Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivoImmunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18.Clinical applications of DNA vaccines: current progress.Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen.A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA VaccineSynthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liverSafety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b triHydrodynamic immunization leads to poor CD8 T-cell expansion, low frequency of memory CTLs and ineffective antiviral protectionIdentificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy.DNA vaccine manufacture: scale and quality.DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft RejectionHuman papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer.Current state in the development of candidate therapeutic HPV vaccinesThe current state of therapeutic and T cell-based vaccines against human papillomaviruses.DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.E6 and E7 fusion immunoglobulin from human papilloma virus 16 induces dendritic cell maturation and antigen specific activation of T helper 1 response.Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.
P2860
Q28069272-F4D7F732-9E48-4063-B192-DE94001E2603Q28236770-2A589610-AE46-46B4-9ADB-F60DB7FF114AQ33680693-3A400912-AD49-4270-97F0-7BCB564CBCBBQ33713435-F29C15B6-7CF6-4660-B2DA-AAD813C7DB64Q33862762-6F786DB7-B22B-4011-B8EB-5836DBBAE220Q33936427-FACBD576-A109-44C1-8ACF-C1BB2735AB9CQ34033763-4642DE46-7DA9-4859-A963-1ADB8D73565AQ34091377-FCBC78EF-3020-4288-B954-9C48203DF638Q34657561-C763320E-9D8E-488D-9030-5B29EA82E4F7Q35049821-3A749A54-D9F5-4BC7-8233-AC3A4F29A0CFQ35082880-B4AC4A6E-BB85-4840-A0C7-610B2F1FC105Q35102892-80A4122B-6ECF-4BB4-9DB8-37F424030F7FQ35452312-9A2C4C2C-2886-4EA1-93B2-B7D614A83DDBQ36184362-0081E411-ED29-4252-97C8-21860B592F4EQ36494733-0B8BDB96-FE83-4806-9CA2-AFB0AE7187D7Q36837548-9C3C7E3B-E9F9-4445-9B57-BB7E85BBCF49Q36871557-1D674D09-A06A-4706-B89E-8803F86A6473Q36954152-46939902-2CA4-4EFF-99BF-7A5F3A34A3BEQ37250507-44F9464F-64E7-42CA-B01A-EAFE434903D6Q37438391-19FC27BB-F668-41C7-8E83-5FA7FF491CCEQ37590348-B9DAA3AE-6B8D-4158-AAB8-F3FC2D2D1C5AQ37626311-A7A2059F-FCCF-477B-93E6-0E3701A47297Q38089937-CFF3F442-C73A-4B1A-BE89-57186A9F5F05Q38743922-20D163EB-AE59-44C3-97DD-A8CFC1D3D357Q39033576-C0F50BEA-E33A-4FC0-98D7-4A14AF44EBCAQ39047929-4851E23B-830A-4113-8C15-25E54EEE3962Q39862468-F50767BA-5A64-42B6-A64E-F7BF4E8FFE0BQ41435861-AAFA5A3B-80FC-4E36-8366-EF76B37E1C6AQ45370701-1A3FFF03-186E-4EE4-ABBC-6118D466257CQ55163909-816B0E51-52AB-4B85-966E-DF23CC22976E
P2860
Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cellular immunity induced by a ...... n in mice and rhesus macaques.
@ast
Cellular immunity induced by a ...... n in mice and rhesus macaques.
@en
type
label
Cellular immunity induced by a ...... n in mice and rhesus macaques.
@ast
Cellular immunity induced by a ...... n in mice and rhesus macaques.
@en
prefLabel
Cellular immunity induced by a ...... n in mice and rhesus macaques.
@ast
Cellular immunity induced by a ...... n in mice and rhesus macaques.
@en
P2093
P2860
P1433
P1476
Cellular immunity induced by a ...... n in mice and rhesus macaques.
@en
P2093
Amir S Khan
David B Weiner
Duane Sewell
Kristina Harris
Ruxandra Draghia-Akli
P2860
P304
P356
10.1016/J.VACCINE.2008.03.069
P407
P577
2008-04-14T00:00:00Z